newsfilter
← Latest News
GlobeNewswire·

LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets

SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today